2011
DOI: 10.1007/s00404-011-2192-3
|View full text |Cite
|
Sign up to set email alerts
|

Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers

Abstract: LD COC uptake results in a significant decrease in serum adiponectin concentration, nonsignificant increase in leptin levels and a more atherogenic lipid profile by significantly increasing LDL and nonsignificantly decreasing HDL concentrations. These findings suggested that COC may reduce or stimulate the adiponectin and leptin concentrations, respectively. This might be due to an effect of these pills on adipocyte maturation via inhibition or stimulation of the synthesis of new adiponectin and leptin molecul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 23 publications
1
11
1
Order By: Relevance
“…The preeclamptic women demonstrated significant dyslipidemia in comparison with the normal pregnant women. Although studies that assessed lipid profile in pregnant women who used progestin-only contraceptive prior to pregnancy remain scarce, data on women who used Combined Oral Contraceptive (COC) indicated that COC uptake results in a more atherogenic lipid profile by increasing LDL-C and decreasing HDL-C concentrations [23]. It has also been suggested that perhaps free radicals produced during metabolism of hormonal contraceptives change the amounts of atherogenic lipids [24].…”
Section: Interpretation Of Resultsmentioning
confidence: 99%
“…The preeclamptic women demonstrated significant dyslipidemia in comparison with the normal pregnant women. Although studies that assessed lipid profile in pregnant women who used progestin-only contraceptive prior to pregnancy remain scarce, data on women who used Combined Oral Contraceptive (COC) indicated that COC uptake results in a more atherogenic lipid profile by increasing LDL-C and decreasing HDL-C concentrations [23]. It has also been suggested that perhaps free radicals produced during metabolism of hormonal contraceptives change the amounts of atherogenic lipids [24].…”
Section: Interpretation Of Resultsmentioning
confidence: 99%
“…Rises in leptin do not necessarily follow the phases of the menstrual cycle in which estrogen levels are highest 86 . In addition, the literature is not consistent in demonstrating that leptin levels increase in women taking oral contraceptives 88, 89 . These data indicate that the ability of estrogen to stimulate leptin, or vice versa, is likely a complex relationship, and further investigation is warranted.…”
Section: Females Lose Protection From Female Sex Hormones In Obesitymentioning
confidence: 92%
“…Participants were excluded because of missing data and use of hormone medications, including systemic corticosteroids (n=2), steroid hormones (n=26), steroid hormones and corticosteroids (n=1), or thyroid hormones (n=41). We excluded participants taking hormone medications (sex steroids, corticosteroid or thyroid) because of potential effects on diabetes biomarkers and HA1c (Brand et al 2011;Fallah et al 2012;Sargeant et al 2000). The final sample size for analysis was 413.…”
Section: Methodsmentioning
confidence: 99%